Innate Immunity Modulation by the IL-33/ST2 System in Intestinal Mucosa

被引:13
|
作者
Garcia-Miguel, Marina [1 ]
Julieta Gonzalez, M. [2 ]
Quera, Rodrigo [3 ]
Hermoso, Marcela A. [1 ]
机构
[1] Univ Chile, Fac Med, Inst Biomed Sci, Disciplinary Program Immunol, Santiago 7, Chile
[2] Univ Chile, Fac Med, Inst Biomed Sci, Cell & Mol Biol Program, Santiago 7, Chile
[3] Clin Las Condes, Gastroenterol Unit, Santiago, Chile
关键词
INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTOR-4; ST2; GENE-PRODUCT; HUMAN MUC2 MUCIN; NF-KAPPA-B; ULCERATIVE-COLITIS; DENDRITIC CELLS; MAST-CELLS; T-CELLS; CROHNS-DISEASE;
D O I
10.1155/2013/142492
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Innate immunity prevents pathogens from entering and spreading within the body. This function is especially important in the gastrointestinal tract and skin, as these organs have a large surface contact area with the outside environment. In the intestine, luminal commensal bacteria are necessary for adequate food digestion and play a crucial role in tolerance to benign antigens. Immune system damage can create an intestinal inflammatory response, leading to chronic disease including inflammatory bowel diseases (IBD). Ulcerative colitis (UC) is an IBD of unknown etiology with increasing worldwide prevalence. In the intestinal mucosa of UC patients, there is an imbalance in the IL-33/ST2 axis, an important modulator of the innate immune response.. is paper reviews the role of the IL-33/ST2 system in innate immunity of the intestinal mucosa and its importance in inflammatory bowel diseases, especially ulcerative colitis.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] IL-33/ST2 as a potential target for tumor immunotherapy
    Jiang, Wenyi
    Lian, Jingyao
    Yue, Ying
    Zhang, Yi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (08) : 1943 - 1955
  • [32] IL-33/ST2 signaling boosts inflammation and pain
    Fattori, Victor
    Borghi, Sergio M.
    Verri, Waldiceu A., Jr.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (47) : E10034 - E10035
  • [33] IL-33/ST2 in angiogenesis and limb ischemia in mice
    Besnier, M.
    Meloni, M.
    Caporali, A.
    Baker, A. H.
    Miller, A.
    Emanueli, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1117 - 1117
  • [34] Upregulation of the IL-33/ST2 pathway in dry eye
    Wang, Shudan
    Zhang, Hong
    MOLECULAR VISION, 2019, 25 : 583 - 592
  • [35] The IL-33/ST2 axis: Role in health and disease
    De la Fuente, Marjorie
    MacDonald, Thomas T.
    Hermoso, Marcela A.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (06) : 615 - 623
  • [36] Characterization of ST2 transgenic mice with resistance to IL-33
    Ohto-Ozaki, Hiromi
    Kuroiwa, Kenji
    Mato, Naoko
    Matsuyama, Yasushi
    Hayakawa, Morisada
    Tamemoto, Hiroyuki
    Tominaga, Shin-ichi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (09) : 2632 - 2642
  • [37] The role of IL-33/ST2 axis in Colorectal Cancer
    Mahmoud, A. M.
    O'Donnell, C. O. D.
    Carey, S. C.
    O'Riordain, M.
    Bennett, M. W. B.
    Brint, E. B.
    Houston, A. H.
    JOURNAL OF PATHOLOGY, 2015, 237 : S43 - S43
  • [38] ST2 and IL-33 in Pregnancy and Pre-Eclampsia
    Granne, Ingrid
    Southcombe, Jennifer H.
    Snider, James V.
    Tannetta, Dionne S.
    Child, Tim
    Redman, Christopher W. G.
    Sargent, Ian L.
    PLOS ONE, 2011, 6 (09):
  • [39] IL-33/ST2 IN ANGIOGENESIS AND LIMB ISCHEMIA IN MICE
    Besnier, M.
    Meloni, M.
    Caporali, A.
    Baker, A. H.
    Miller, A. M.
    Emanueli, C.
    ATHEROSCLEROSIS, 2015, 241 (01) : E22 - E22
  • [40] Soluble ST2 (sST2) and IL-33 in preeclampsia
    Granne, I.
    Southcombe, J.
    Snider, J. V.
    Child, T.
    Redman, C. W.
    Sargent, I. L.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2010, 86 (01) : 65 - 65